Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma 74Lymphoma, Large B-Cell, Diffuse 55Lymphoma, Non-Hodgkin 54Glioblastoma 41Lymphoma, Mantle-Cell 40Lymphoma, Follicular 37Hodgkin Disease 36Central Nervous System Neoplasms 32Gliosarcoma 29Brain Neoplasms 28Astrocytoma 28Lymphoma, Large-Cell, Immunoblastic 26Burkitt Lymphoma 25Multiple Myeloma 22Leukemia, Lymphocytic, Chronic, B-Cell 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Glioma 20Oligodendroglioma 16Lymphoma, B-Cell, Marginal Zone 15Neoplasms, Plasma Cell 14Leukemia 13Recurrence 10Lymphoma, B-Cell 9Lymphoma, T-Cell 8Waldenstrom Macroglobulinemia 6Lymphoma, T-Cell, Cutaneous 6Leukemia, Myeloid, Acute 6Ependymoma 6Lymphoma, T-Cell, Peripheral 5Lymphoma, Large-Cell, Anaplastic 5

Interventions

Cyclophosphamide 23blinatumomab 18Cytarabine 16fludarabine 13Azacitidine 12venetoclax 10fludarabine phosphate 10Rituximab 8Blood Specimen Collection 8Methotrexate 7Lenalidomide 7Dexamethasone 7Daunorubicin 7Mercaptopurine 6Vincristine 5daratumumab 4Whole-Body Irradiation 4Melphalan 4Idarubicin 4Etoposide 4Drug Therapy 4Busulfan 4pembrolizumab 3obinutuzumab 3Radiotherapy 3Neoadjuvant Therapy 3Maintenance 3Liquid Biopsy 3Immunotherapy, Adoptive 3Imatinib Mesylate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm, Residual × Carmustine × Clear all
NCT02670109 2020-01-14

Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Phase 2 Unknown
20 enrolled
Tumor-Agnostic

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡